Mn 3 O 4 Nanozyme Loaded Thermosensitive PDLLA-PEG-PDLLA Hydrogels for the Treatment of Inflammatory Bowel Disease
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.3c03332 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2023. Written by Zhongke Yang and 11 co-authors. Institution: College of Science, Sichuan Agricultural University, Chengdu 611130, Sichuan, China. Major MEDLINE topics: Inflammatory Bowel Diseases, Colitis. Cited 57 times so far (Crossref); 58 references. Funded by: Department of Science and Technology of Sichuan Province, National Natural Science Foundation of China.
Abstract (original language)
When reactive oxygen species (ROS) accumulate in the body, they can lead to inflammatory bowel disease (IBD) through their oxidative damages to DNA, proteins, and lipids. In this study, a thermosensitive hydrogel-based nanozyme was developed to treat IBD. We first synthesized a manganese oxide (Mn3O4) nanozyme with multienzyme activity followed by physically loading with a thermosensitive hydrogel poly(d,l-lactide)-poly(ethylene glycol)-poly(d,l-lactide)-based triblock copolymer (PDLLA-PEG-PDLLA). Then, a mouse model based on the inducement of dextran sulfate sodium (DSS) was built to assess the ROS targeting, scavenging, as well as anti-inflammatory ability of Mn3O4 nanozymes-loaded PDLLA-PEG-PDLLA (MLPPP). Because of the sharp gelation behavior of PDLLA-PEG-PDLLA in body temperature, the MLPPP nanozyme can easily target the inflamed colon after colorectal administration. Following the formation of a physical protection barrier and sustained release of manganese oxide nanozymes that had diverse enzymatic activities and can effectively scavenge ROS, the administration of the MLPPP nanozyme had a high efficacy for treating colitis mice; importantly, after the treatment with this novel nanoformulation, the levels of the pathological indicators in colons as well as in sera of colitis mice were even comparable to healthy mice. Therefore, the MLPPP nanozyme has a potential application for nanotherapy of IBD and would have great clinical translation prospects.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Science, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
- College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
- Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
- Dafeng Street Taiping Community Health Service Center, Chengdu 610504, Sichuan, China.
ORCID profiles: Xianxiang Wang
Funding
- Department of Science and Technology of Sichuan Province
- National Natural Science Foundation of China
Cite
APA
Yang, Z., Zhou, X., Wang, L., Guo, H., Han, M., Guo, H., Chen, Y., Wu, A., Li, H., Chen, S., Xie, Y., & Wang, X. (2023). Mn 3 O 4 Nanozyme Loaded Thermosensitive PDLLA-PEG-PDLLA Hydrogels for the Treatment of Inflammatory Bowel Disease. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c03332
Vancouver
Yang Z, Zhou X, Wang L, Guo H, Han M, Guo H, et al. Mn 3 O 4 Nanozyme Loaded Thermosensitive PDLLA-PEG-PDLLA Hydrogels for the Treatment of Inflammatory Bowel Disease. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c03332
BibTeX
@article{Yang2023,
author = {Yang, Zhongke and Zhou, Xuan and Wang, Lidan and Guo, Hai and Han, Ming and Guo, Hongrui and Chen, Yinyin and Wu, Aimin and Li, Hongyan and Chen, Shun and Xie, Yue and Wang, Xianxiang},
title = {Mn 3 O 4 Nanozyme Loaded Thermosensitive PDLLA-PEG-PDLLA Hydrogels for the Treatment of Inflammatory Bowel Disease},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.3c03332}
}
EUVIMED